Innoblative Receives U.S. FDA Breakthrough Device Designation for its SIRA RFA Electrosurgical Device
Novel device is designed specifically for patients undergoing breast-conserving surgery (BCS) for breast cancer CHICAGO, April 27, 2023 /PRNewswire/ — Innoblative Designs, Inc. (Innoblative),